BiovitalsHF® Approved for Expedited FDA Review Process as a First-in-Class DTx for Heart Failure that Augments Traditional Guideline-Directed Medical Therapy BOSTON, July 29, 2021 –

Sheeza Khawar Hussain to Accelerate Market Growth for Biofourmis’ Care-at-Home Technology Solutions, including Hospital at Home    BOSTON, June 23, 2021 – Biofourmis, a Boston-based

Former Amazon Medical Officer and Massachusetts General Hospital Cardiologist to Lead Product Management, Data Science and Clinical Affairs for Fast-Growing Tech-Enabled Care Delivery Company BOSTON, May

– To immediately expand hospital capacity during the COVID-19 public health emergency, CMS has announced the Acute Hospital at Home program waiver that provides full

Funding to advance “home hospital” initiatives with health systems and “beyond the pill” digital therapeutics partnerships with pharmaceutical companies BOSTON, Sept. 3, 2020 /PRNewswire/ — Biofourmis, a fast-growing

– COVID-19 patients in Singapore are being monitored using Biofourmis’ cutting-edge wearable and artificial intelligence technology to accelerate disease surveillance and interventions – Biofourmis staff

– Chugai and Biofourmis are partnering to develop a digital solution leveraging Biofourmis’ Biovitals® platform for pain management in patients with endometriosis – A non-interventional

Finance leader Matt Borowiecki brings deep M&A and fundraising experience to his new role   BOSTON, May 26, 2020 /PRNewswire/ — Biofourmis, a fast-growing global leader in digital

Acquisition of Gaido Health from Takeda Digital Ventures builds Biofourmis’ digital therapeutics portfolio in oncology, while improving the care experience for cancer patients and providers

– First-of-its-kind program administered by The University of Hong Kong has international implications and applications as COVID-19 continues to spread – Clinicians to leverage Biofourmis’

Biofourmis’ artificial intelligence-powered RhythmAnalytics® to provide clinical decision support that IDs cardiac arrhythmias and other issues requiring intervention BOSTON, Jan. 30, 2020 /PRNewswire/ — Biofourmis, a fast-growing global

COO Jaydev Thakkar brings deep clinical trial and digital therapeutics experience; CTO Milan Shah is a former Microsoft developer who has grown and sold four

– Novartis to leverage Biofourmis’ lead digital therapeutics product to remotely manage patients with heart failure across Asia – Alliance combines Novartis access solutions for

Acquisition of Biovotion establishes Biovitals® as the most comprehensive predictive digital therapeutics solution for healthcare providers, payers and pharmaceutical companies by combining best-in-class medical data

Milestone approval establishes AI-powered solution as the foundation for future disease-specific predictive management tools from Biofourmis   BOSTON, Oct. 3, 2019 /PRNewswire/ — Biofourmis, a fast-growing global leader

CEO Kuldeep Singh Rajput will also speak at CB Insights’ Future of Health conference about what’s ahead for digital therapeutics   NEW YORK, Oct. 2, 2019 /PRNewswire/

Biofourmis’ innovative technology to measure patient-centric endpoints to inform future drug development   BOSTON, July 16, 2019 /PRNewswire/ — Biofourmis, a fast-growing global leader in digital therapeutics, has

Funding to grow clinically validated solution that combines AI, drug therapies, wearable sensors and smartphone app to deliver better patient outcomes   BOSTON, May 21, 2019 /PRNewswire/